| Literature DB >> 33720991 |
Cédric Lood1,2, Charlotte Peeters3, Quentin Lamy-Besnier1, Jeroen Wagemans1, Daniel De Vos4, Marijke Proesmans5, Jean-Paul Pirnay4, Fedoua Echahidi6, Denis Piérard6, Matthieu Thimmesch7, Anca Boeras8, Katrien Lagrou9,10, Evelien De Canck3, Elke De Wachter11, Vera van Noort2,12, Rob Lavigne1, Peter Vandamme3.
Abstract
Burkholderia multivorans is a member of the Burkholderia cepacia complex (Bcc), notorious for its pathogenicity in persons with cystic fibrosis. Epidemiological surveillance suggests that patients predominantly acquire B. multivorans from environmental sources, with rare cases of patient-to-patient transmission. Here we report on the genomic analysis of thirteen isolates from an endemic B. multivorans strain infecting four cystic fibrosis patients treated in different pediatric cystic fibrosis centers in Belgium, with no evidence of cross-infection. All isolates share an identical sequence type (ST-742) but whole genome analysis shows that they exhibit peculiar patterns of genomic diversity between patients. By combining short and long reads sequencing technologies, we highlight key differences in terms of small nucleotide polymorphisms indicative of low rates of adaptive evolution within patient, and well-defined, hundred kbps-long segments of high enrichment in mutations between patients. In addition, we observed large structural genomic variations amongst the isolates which revealed different plasmid contents, active roles for transposase IS3 and IS5 in the deactivation of genes, and mobile prophage elements. Our study shows limited within-patient B. multivorans evolution and high between-patient strain diversity, indicating that an environmental microdiverse reservoir must be present for this endemic strain, in which active diversification is taking place. Furthermore, our analysis also reveals a set of 30 parallel adaptations across multiple patients, indicating that the specific genomic background of a given strain may dictate the route of adaptation within the cystic fibrosis lung.Entities:
Year: 2021 PMID: 33720991 PMCID: PMC7993779 DOI: 10.1371/journal.ppat.1009418
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823